Women’s Health Wellness

Periodic screening 

• Chlamydia and Gonorrhea (annually for ages 13-24)
• Human immunodeficiency virus (HIV): Age 13-65: Test at least once during lifetime; at least once a year if at increased risk
• Hepatitis B screening (if pregnant)
• Syphilis testing (if pregnant)
   

Screening if at increased risk

• Diabetes testing (every three years with previous gestational diabetes for at least 10 years after pregnancy) with previous gestational diabetes, every 3 years for at least 10 years after pregnancy
• Hepatitis B screening
• Syphilis testing
• Tuberculosis testing

Periodic screening 

• Cervical cytology
  • Ages 21-29: Every three years with cytology alone
  • Ages 30 to 65: Screen every 3 years with cytology alone, every 5 years with high-risk HPV testing alone, or co-testing every 5 years.
• Chlamydia and Gonorrhea (annually if aged 24 or younger and sexually active; annually if at increased risk)
• Genetic testing/counseling (SMA, CF and screening for thalassemias and hemoglobinopathies should be offered in women considering pregnancy and who are pregnant)
• Human immunodeficiency virus (HIV): Age 13-65: Test at least once during lifetime; at least once a year if at increased risk
• Hepatitis C screening  (one-time screening for asymptomatic adults ages 18-79; repeat screening for high-risk patients)
• Hepatitis B screening (if pregnant)
• Lipid screening (once between ages 18-21
• Syphilis testing (if pregnant)
   

Screening if at increased risk

• Diabetes testing (every three years with previous gestational diabetes for at least 10 years after pregnancy)
• Periodic assessment and genetic counseling/genetic testing for women with a personal or family history of breast, ovarian, tubal or peritoneal cancer or who have relative(s) with a cancer susceptibility gene mutation
• Syphilis testing
• Thyroid Stimulating Hormone in symptomatic women
• Tuberculosis testing
• Hepatitis B screening

Periodic screening 

• Colorectal cancer screening beginning at age 45 (African American women and those with a family history of colorectal cancer may consider screening at an earlier age)
• Cervical cytology (Ages 30 to 65: Screen every 3 years with cytology alone, every 5 years with high-risk HPV testing alone, or co-testing every 5 years.)
• Lipid screening (every five years)
• Genetic testing/counseling (SMA, CF and assessment for risk of hemoglobinopathy should be offered in women considering pregnancy and who are pregnant)
• Hepatitis C screening  (one-time screening for asymptomatic adults ages 18-79; repeat screening for high-risk patients)
• Syphilis testing (if pregnant)
• Human immunodeficiency virus (HIV): Age 13-65: Test at least once during lifetime; at least once a year if at increased risk
• Chlamydia and Gonorrhea (annual screening if at increased risk) 
• Hepatitis B screening (if pregnant)
   

Screening if at increased risk

• Diabetes testing (every three years with previous gestational diabetes for at least 10 years after pregnancy)
• Periodic assessment and genetic counseling/genetic testing for women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have relative(s) with a cancer susceptibility gene mutation
• Syphilis testing
• Thyroid Stimulating Hormone in symptomatic women
• Tuberculosis testing
• Hepatitis B screening

Periodic screening 

• Colorectal cancer screening aged up to age 75 and then 76-85 (based on patient’s overall health)
• Cervical cytology
  • Ages 30 to 65: Screen every three years with cytology alone, every five years with high-risk HPV testing alone, or co-testing every five years
  • Age 66 and older: Discontinue in women with evidence of adequate negative prior screening test results and no history of CIN 2 or higher
• Lipid screening (every five years up to age 75)
• Diabetes testing (every three years if overweight or obese)
• Hepatitis C screening (at least once for ages 18-79; repeat screening for high-risk patients)
• Chlamydia and Gonorrhea (annual screening if at increased risk)
   

Screening if at increased risk

• Human immunodeficiency virus (HIV)
• Periodic assessment and genetic counseling/genetic testing for women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have relative(s) with a cancer susceptibility gene mutation
• Syphilis testing
• Thyroid Stimulating Hormone in symptomatic women
• Tuberculosis testing
• Hepatitis B screening